We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.21%
This Fund
S&P 500
This Quarter
Est. Return
+1.6%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$7.25B
AUM Growth
-$573M
(-7.3%)
Cap. Flow
-$1.34B
Cap. Flow
% of AUM
-18.42%
Top 10 Holdings %
Top 10 Hldgs %
9.84%
Holding
1,815
New
681
Increased
271
Reduced
326
Closed
465
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$65.6M |
| 2 |
Ralph Lauren
RL
|
+$63.1M |
| 3 |
Mattel
MAT
|
+$59.7M |
| 4 |
United Rentals
URI
|
+$55.1M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$54.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$77.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$72.1M |
| 3 |
Halliburton
HAL
|
+$68.2M |
| 4 |
Verizon
VZ
|
+$67M |
| 5 |
Las Vegas Sands
LVS
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.11% |
| 2 | Consumer Discretionary | 11.46% |
| 3 | Industrials | 7.53% |
| 4 | Technology | 7.47% |
| 5 | Financials | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWTR
951
DELISTED
Twitter, Inc.
TWTR
| $429K | 0.01% |
8,574
-1,758,103
| -100% | -$77.9M |
|
|
RPRX
952
DELISTED
Repros Therapeutics Inc.
RPRX
| $429K | 0.01% |
49,930
-104,410
| -68% | -$934K |
|
953
Gogo Inc
GOGO
$492M
| $425K | 0.01% |
+22,302
| New | +$380K |
|
954
CALL
Mastercard
MA
$505B
| $424K | 0.01% |
+4,900
| New | +$425K |
|
955
PUT
Quest Diagnostics
DGX
$26.3B
| $422K | 0.01% |
5,500
+2,500
| +83% | +$179K |
|
|
TYC
956
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $422K | 0.01% |
9,361
-7,640
| -45% | -$340K |
|
957
Vanda Pharmaceuticals
VNDA
$308M
| $420K | 0.01% |
45,112
+10,758
| +31% | +$122K |
|
|
DNR
958
DELISTED
Denbury Resources, Inc.
DNR
| $418K | 0.01% |
57,238
-1,810,964
| -97% | -$14M |
|
|
VIVO
959
DELISTED
Meridian Bioscience Inc
VIVO
| $417K | 0.01% |
+21,864
| New | +$404K |
|
960
AMN Healthcare
AMN
$1.19B
| $416K | 0.01% |
+18,051
| New | +$373K |
|
961
CALL
IBM
IBM
$220B
| $416K | 0.01% |
+2,720
| New | +$413K |
|
962
InterDigital
IDCC
$8.47B
| $416K | 0.01% |
+8,196
| New | +$425K |
|
|
X
963
CALL
DELISTED
US Steel
X
| $414K | 0.01% |
+17,000
| New | +$403K |
|
|
VTAE
964
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $414K | 0.01% |
+35,315
| New | +$476K |
|
965
Theravance Biopharma
TBPH
$877M
| $409K | 0.01% |
23,568
-34,205
| -59% | -$627K |
|
|
TRUE
966
PUT
DELISTED
TrueCar
TRUE
| $409K | 0.01% |
22,900
-18,600
| -45% | -$347K |
|
967
CALL
Precigen
PGEN
$2.47B
| $404K | 0.01% |
+9,312
| New | +$335K |
|
|
SPWR
968
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
| $404K | 0.01% |
19,698
-50,239
| -72% | -$948K |
|
969
Lattice Semiconductor
LSCC
$18.3B
| $403K | 0.01% |
63,652
+17,825
| +39% | +$118K |
|
970
Matrix Service
MTRX
$330M
| $402K | 0.01% |
+22,857
| New | +$430K |
|
|
OMG
971
DELISTED
OM GROUP INC.
OMG
| $402K | 0.01% |
+13,373
| New | +$389K |
|
972
Fortress Biotech
FBIO
$92M
| $398K | 0.01% |
+6,898
| New | +$288K |
|
973
Capri Holdings
CPRI
$1.72B
| $397K | 0.01% |
6,039
-1,765
| -23% | -$121K |
|
974
Bruker
BRKR
$7.8B
| $394K | 0.01% |
+21,338
| New | +$404K |
|
975
PUT
Salesforce
CRM
$153B
| $394K | 0.01% |
5,900
-3,500
| -37% | -$217K |
|
Similar funds
CAM
MRCP
ECP
TCG
PC
CCI
DIG
CLG
Highbridge Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Highbridge Capital Management held 1,815 positions worth $7.25B, down 7.3% from $7.82B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Highbridge Capital Management withdrew a net $1.34B in Q1 2015, closing 465 positions and reducing 326 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $72.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.8% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Highbridge Capital Management opened a new position in Ralph Lauren worth $56.1M.
- Highbridge Capital Management's largest Q1 2015 buy was Ralph Lauren: 426,310 shares worth $56.1M.
- Highbridge Capital Management added most to AbbVie in Q1 2015, an estimated $65.6M increase.
- Highbridge Capital Management's biggest Q1 2015 reduction was Twitter, Inc., cutting an estimated $77.9M.
- Highbridge Capital Management fully exited Alphabet (Google) Class C in Q1 2015, selling an estimated $72.1M.
- Highbridge Capital Management's ten largest holdings make up 9.8% of its $7.25B portfolio in Q1 2015.
- Highbridge Capital Management opened 681 new positions and closed 465 in Q1 2015.
- Highbridge Capital Management's portfolio value fell 7.3% quarter-over-quarter to $7.25B.
Based on Highbridge Capital Management's 13F filing for Q1 2015, filed 15 May 2015.